Development and Validation of a Magnetic Microsphere-Assisted Fluorescence Assay for LL37 Detection Based on a Nucleic Acid Aptamer
Antimicrobial peptide LL37, a cationic small peptide composed of 37 amino acids, serves as a potential biomarker for autoimmune diseases. However, its quantitative detection remains challenging due to its low molecular weight and poor immunogenicity. Therefore available methods of LL37 detection are often complex, time-consuming, and expensive. In this study, a magnetic microsphere fluorescence assay based on a nucleic acid aptamer was developed for LL37 quantification. The aptamer (Apt-01) was labeled with Cy3 and biotin at the end of 3′ and 5′, respectively, and a BHQ2-labeled complementary DNA served as a quencher. Upon target binding, a dose-dependent fluorescence recovery consistent with cDNA displacement by LL37 was observed. Under optimized aptamer and cDNA concentrations, as well as incubation time, the assay exhibited a favorable linear range of 0.5–20 ng/mL (R2 = 0.9941) with a limit of detection of 0.089 ng/mL. Spike recovery rates ranged from 85% to 116% with relative standard deviations below 10%. Moreover, the detection results of LL37 showed good concordance with those of a commercial ELISA kit, with deviations of RSD in ±3.0%. In conclusion, the aptamer-based microsphere fluorescence assay offers a practical alternative to antibody dependent approaches for LL37 detection. This platform also holds great potential for broad application in autoimmune disease diagnostics.
Authors
- Zhenfei Peng
- Changwen You (ORCID: https://orcid.org/0009-0003-9966-4842)
- Haiying Lin
- Liying Ye
- Liping Xu
- Yongning Li
Institutions
- Fujian Health College (CN)
- Fuzhou University (CN)
Publication Details
- Journal
- Biosensors
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/bios16110664
- Primary Topic
- Advanced biosensing and bioanalysis techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00